Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)
Lithium
44.97
0.87%
Gold
2,718.20
1.73%
Copper
4.09
(0.58%)
Oil
71.18
1.42%
Bitcoin
98,548.30
(0.46%)
FTSE 100
8,262.08
1.38%
Nikkei 225
38,283.85
0.36%
Dow Jones
44,296.51
0.97%
Iron Ore
100.20
(1.77%)
USD/AUD
0.65
0%
Hang Seng
19,229.97
(1.96%)

Immuron Ltd

IMC

ASX

Immuron Limited (IMC) is commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of specifically targeted polyclonal antibodies in the treatment of diseases with associated with the gastrointestinal tract. The group is involved in Research & Development and Hyperimmune Products (occur predominantly in Australia, the Unites States and Canada).

Latest Posts

Line Chart with Gradient
Price
$0.075
0 (0%)
At Close 22/11 (AEST)
Related Companies
CLINUVEL PHARMACEUTICALS LIMITED
$CUV
STARPHARMA HOLDINGS LIMITED
$SPL
CANN GROUP LIMITED
$CAN
RACE ONCOLOGY LTD
$RAC
NANOLLOSE LIMITED
$NC6

Leave a Comment on IMC


Comments for IMC

    Latest Posts

    immuron-asx-imc-completes-interim-analysis-for-nmrc-clinical-trial-imc
    Health Care $IMC

    Immuron (ASX: $IMC) completes interim analysis for NMRC clinical trial

    NMRC completes clinical evaluation of new oral therapeutic targeting Campylobacter and ETEC

    October 4, 2024
    immuron-asx-imc-requests-trading-halt-for-clinical-trial-data-analysis-imc
    Health Care $IMC

    Immuron (ASX: $IMC) requests trading halt for clinical trial data analysis

    Trading halt requested to analyze CampETEC Hyperimmune Bovine Colostrum clinical trial data

    October 3, 2024
    immuron-asx-imc-reports-strong-growth-in-travelan-sales-imc
    Health Care $IMC

    Immuron (ASX: $IMC) reports strong growth in Travelan sales

    Record sales of Travelan immune supplement in Australia and USA

    April 10, 2024
    immuron-asx-imc-progresses-to-phase-3-clinical-trials-in-the-us-imc
    Health Care $IMC

    Immuron (ASX: $IMC) progresses to phase 3 clinical trials in the us

    Travelan topline clinical trial results demonstrate protective efficacy with single daily dose

    March 7, 2024
    immuron-asx-imc-requests-trading-halt-for-phase-2-imm-124e-clinical-trial-top-line-results-imc
    Health Care $IMC

    Immuron (ASX: $IMC) requests trading halt for Phase 2 IMM-124E clinical trial top-line results

    Company requests halt to analyze data before announcing clinical trial results

    March 5, 2024
    immuron-asx-imc-initiates-campylobacter-challenge-clinical-study-imc
    Health Care $IMC

    Immuron (ASX: $IMC) initiates campylobacter challenge clinical study

    US Naval Medical Research Command commences evaluation of new Immuron clinical product

    January 12, 2024
    immuron-asximc-initiates-campylobacter-challenge-clinical-study-imc
    Health Care $IMC

    Immuron (ASX:$IMC) initiates campylobacter challenge clinical study

    US Naval Medical Research Command commences evaluation of new Immuron clinical product

    December 4, 2023
    immuron-asx-imc-plans-phase-2-trial-for-imm-529-following-fda-review-imc
    Health Care $IMC

    Immuron (ASX: $IMC) plans phase 2 trial for imm-529 following FDA review

    Set to file IND application for IMM-529 to prevent or treat Clostridioides difficile infection

    September 5, 2024

    IMC

    $IMC

    Immuron (ASX: $IMC) completes interim analysis for NMRC clinical trial

    NMRC completes clinical evaluation of new oral therapeutic targeting Campylobacter and ETEC

    IMC

    $IMC

    Immuron (ASX: $IMC) requests trading halt for clinical trial data analysis

    Trading halt requested to analyze CampETEC Hyperimmune Bovine Colostrum clinical trial data

    IMC

    $IMC

    Immuron (ASX: $IMC) reports strong growth in Travelan sales

    Record sales of Travelan immune supplement in Australia and USA

    IMC

    $IMC

    Immuron (ASX: $IMC) progresses to phase 3 clinical trials in the us

    Travelan topline clinical trial results demonstrate protective efficacy with single daily dose

    IMC

    $IMC

    Immuron (ASX: $IMC) requests trading halt for Phase 2 IMM-124E clinical trial top-line results

    Company requests halt to analyze data before announcing clinical trial results

    IMC

    $IMC

    Immuron (ASX: $IMC) initiates campylobacter challenge clinical study

    US Naval Medical Research Command commences evaluation of new Immuron clinical product

    IMC

    $IMC

    Immuron (ASX:$IMC) initiates campylobacter challenge clinical study

    US Naval Medical Research Command commences evaluation of new Immuron clinical product

    Related Companies
    MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
    $MVP
    AVITA MEDICAL INC.
    $AVH
    VITA LIFE SCIENCES LIMITED..
    $VLS
    PERCHERON THERAPEUTICS LIMITED
    $PER
    TELIX PHARMACEUTICALS LIMITED
    $TLX

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions